| Lynch Group Holdings Limited (LGL) ORDINARY FULLY PAID |
Consumer Staple |
- |
Becoming a substantial holder from MS
|
27 Aug 2025 4:23PM |
$2.180 |
$2.150 |
fallen by
1.38%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$30 |
Appendix 4G and Corporate Governance statement
|
27 Aug 2025 4:22PM |
$0.145 |
$0.105 |
fallen by
27.59%
|
|
| Lanyon Investment Fund Active ETF (LNYN) |
Financials |
$153 |
Quarterly Portfolio Disclosure June 2025
|
27 Aug 2025 4:22PM |
$1.715 |
$1.955 |
risen by
13.99%
|
|
| Sunstone Metals Ltd (STM) ORDINARY FULLY PAID |
Materials |
$48 |
Application for quotation of securities - STM
|
27 Aug 2025 4:21PM |
$0.018 |
$0.210 |
risen by
1,066.67%
|
|
| Savannah Goldfields Limited (SVG) ORDINARY FULLY PAID |
Materials |
$25 |
Target Market Determination
|
27 Aug 2025 4:21PM |
$0.016 |
$0.011 |
fallen by
31.25%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$30 |
Full year Financial Results
|
27 Aug 2025 4:20PM |
$0.145 |
$0.105 |
fallen by
27.59%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported full year financial results for period ended 30 June 2023.
- Total revenue increased to $18.2 million, driven by growth in the US market and iTrack Advance device sales.
- Statutory net loss after tax of $7.3 million, attributed to non-cash write-downs and increased investment in sales and marketing.
- Transition to a direct sales model in the US is progressing, improving sales execution and customer reach.
- Secured regulatory approval for iTrack Advance in Canada and South Africa, with launches in additional markets planned.
- Initiated clinical studies to support product adoption and demonstrate clinical efficacy.
- Ongoing investment in R&D and new product pipeline, with focus on minimally invasive glaucoma surgery (MIGS) technologies.
- Positive sales momentum is expected to continue in FY24, with focus on expanding global presence and clinical data generation.
- Company maintains a strong cash position to support growth initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Savannah Goldfields Limited (SVG) ORDINARY FULLY PAID |
Materials |
$25 |
Prospectus
|
27 Aug 2025 4:20PM |
$0.016 |
$0.011 |
fallen by
31.25%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$30 |
Appendix 4E and Annual Report
|
27 Aug 2025 4:19PM |
$0.145 |
$0.105 |
fallen by
27.59%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Nova Eye Medical Limited’s principal activities focus on developing and marketing technologies for treating glaucoma.
- The company’s two core products are the iTrack Advance canaloplasty device and Molteno3 glaucoma drainage device.
- For the year ended 30 June 2023, Nova Eye reported a net loss after tax of $4.7 million, with revenue of $15.7 million.
- No dividends were declared or paid during the reported period.
- The company expanded its commercial operations in the United States and internationally, strengthening its sales and distribution network.
- Nova Eye’s research and development efforts included enhancements to the iTrack Advance device and development of new glaucoma treatment technologies.
- The report outlines the company’s strategy to grow its market share, improve clinical outcomes, and maintain technological leadership in minimally invasive glaucoma surgery.
- Directors and senior management provide an extensive review of operations, financial performance, and risk factors.
- The remuneration report details compensation for key management personnel.
- Corporate governance, auditor’s independence, and risk management processes are summarized.
- Nova Eye continues to prioritize investment in product development and clinical studies, aiming for future revenue growth and improved profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$42 |
Proposed issue of securities - AGR
|
27 Aug 2025 4:19PM |
$0.027 |
$0.019 |
fallen by
29.63%
|
|
| Challenger Gold Limited (CEL) ORDINARY FULLY PAID |
Materials |
$329 |
Section 708A Notice
|
27 Aug 2025 4:18PM |
$0.120 |
$0.125 |
risen by
4.17%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,693 |
Mesoblast 2025 Full Year Financial Results Webcast
|
27 Aug 2025 4:17PM |
$2.490 |
$2.080 |
fallen by
16.47%
|
|
| Gateway Mining Limited (GML) ORDINARY FULLY PAID |
Materials |
$121 |
Ceasing to be a substantial holder
|
27 Aug 2025 4:17PM |
$0.045 |
$0.052 |
risen by
15.56%
|
|
| Challenger Gold Limited (CEL) ORDINARY FULLY PAID |
Materials |
$329 |
Application for quotation of securities - CEL
|
27 Aug 2025 4:16PM |
$0.120 |
$0.125 |
risen by
4.17%
|
|
| Challenger Gold Limited (CEL) ORDINARY FULLY PAID |
Materials |
$329 |
Application for quotation of securities - CEL
|
27 Aug 2025 4:16PM |
$0.120 |
$0.125 |
risen by
4.17%
|
|
| ARC Funds Limited (ARC) ORDINARY FULLY PAID |
Financials |
$6 |
Chief Financial Officer Appointment
|
27 Aug 2025 4:14PM |
$0.099 |
$0.075 |
fallen by
24.24%
|
|
| Infragreen Group Limited (IFN) ORDINARY FULLY PAID |
Industrials |
$52 |
FY25 Annual Results Presentation
|
27 Aug 2025 4:14PM |
$1.195 |
$0.385 |
fallen by
67.78%
|
|
IFN - Price-sensitive ASX Announcement
Full Release
Key Points
- Overview of IFN’s infrastructure investment portfolio and performance
- Summary of FY25 financial results and key operational metrics
- Details on acquisitions, disposals, and portfolio adjustments during the year
- Analysis of returns to shareholders and dividend policy
- Focus on sustainability and ESG initiatives within the portfolio
- Outlook on future investment opportunities and market trends
- Discussion of risk management strategies and identified challenges
- Update on capital management, funding, and debt structure
- Strategic priorities and objectives for the next fiscal year
- Commitment to long-term shareholder value creation
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,498 |
Ceasing to be a substantial holder
|
27 Aug 2025 4:14PM |
$5.220 |
$4.750 |
fallen by
9%
|
|
| Infragreen Group Limited (IFN) ORDINARY FULLY PAID |
Industrials |
$52 |
FY25 Annual Results Announcement
|
27 Aug 2025 4:14PM |
$1.195 |
$0.385 |
fallen by
67.78%
|
|
IFN - Price-sensitive ASX Announcement
Full Release
Key Points
- Infragreen Group Limited announced its FY25 annual results on 26 June 2024.
- The company achieved significant revenue growth and increased net profit compared to the previous year.
- Key business activities included infrastructure investment and green asset management across Asia.
- A final dividend is proposed, indicating a focus on shareholder value.
- Management provided a detailed review of financial performance, operational highlights, and strategic initiatives.
- The annual results include discussions on market risks, sustainability, and corporate governance practices.
- Future outlook projects continued expansion and investment in green infrastructure assets.
- Compliance statements and major transactions during the year are disclosed in the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infragreen Group Limited (IFN) ORDINARY FULLY PAID |
Industrials |
$52 |
Appendix 4E and FY25 Annual Report
|
27 Aug 2025 4:13PM |
$1.195 |
$0.385 |
fallen by
67.78%
|
|
IFN - Price-sensitive ASX Announcement
Full Release
Key Points
- Infragreen Group Limited changed its name from IFN during the reporting period.
- The Appendix 4E outlines financial performance for the year ended 30 June 2024.
- Key financial metrics include net profit/loss, revenue, and dividends for FY25.
- Corporate events include board changes and a company rebranding.
- Operational highlights and strategic initiatives for the year are discussed.
- The report details major risks, uncertainties, and corresponding mitigation strategies.
- Corporate governance and remuneration reports are included.
- The Directors have declared the accuracy and integrity of the financial statements.
- An auditor's independence declaration accompanies the financial report.
- Future outlook and strategic direction are provided by company management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Axtec Limited (AXI) ORDINARY FULLY PAID |
Real Estate |
$7 |
AGM Timetable
|
27 Aug 2025 4:12PM |
$0.016 |
$0.013 |
fallen by
18.75%
|
|
| Rio Tinto Limited (RIO) ORDINARY FULLY PAID |
Materials |
$63,645 |
Rio Tinto operating model & executive team updates
|
27 Aug 2025 4:06PM |
$116.760 |
$171.170 |
risen by
46.60%
|
|
| Perpetual Equity Investment Company Limited (PIC) ORDINARY FULLY PAID |
Financials |
$453 |
Daily Net Tangible Asset Statement
|
27 Aug 2025 4:03PM |
$1.290 |
$1.175 |
fallen by
8.91%
|
|
| Kina Securities Limited (KSL) ORDINARY FULLY PAID |
Financials |
$381 |
1H 2025 Consolidated Financial Statements
|
27 Aug 2025 4:03PM |
$1.380 |
$1.295 |
fallen by
6.16%
|
|
| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$562 |
MA1 - Update to Entitlement Timetable
|
27 Aug 2025 4:00PM |
$2.060 |
$2.010 |
fallen by
2.43%
|
|
| Southern Cross Electrical Engineering Ltd (SXE) ORDINARY FULLY PAID |
Industrials |
$1,314 |
Change of Director's Interest Notice
|
27 Aug 2025 3:57PM |
$1.925 |
$4.330 |
risen by
124.94%
|
|
Call 1300 880 160
Start a chat
Schedule a call
